Harold E Selick - Director, Protagonist Therapeutics, Inc

As of May 28, 2021


Harold E Selick Net Worth

  • Net worth is estimated to be at least $1.92M
  • Owns at least 15,310 units of Protagonist Therapeutics, Inc stock

Harold E Selick Trading

  • Largest purchase of shares was 12,000 units , worth over $80.4K on March 12, 2020
  • In total has made about 5 transactions over 2 years
  • Usually trades in May, with the busiest year in 2020 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Protagonist Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Dinesh V. Patel, Ph.D. 2020 $565,000 - $1,183,155 $473,894 $3,573 $2,225,622
Dinesh V. Patel, Ph.D. 2019 $545,000 $230,575 $814,355 $354,250 $4,164 $1,948,344
David Y. Liu, Ph.D. 2020 $441,300 - $352,429 $266,987 $11,133 $1,071,849
David Y. Liu, Ph.D. 2019 $428,450 $120,300 $424,881 $218,509 $7,458 $1,199,598
Suneel Gupta, Ph.D. 2020 $420,000 - $427,950 $256,200 $4,120 $1,108,270
Suneel Gupta, Ph.D. 2019 $377,467 $60,150 $693,789 $196,767 $3,564 $1,331,737
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1377121/000110465921050202/tm212463-1_def14a.htm

Protagonist Therapeutics, Inc Insider Trading

  • The most recent transaction was 15,000 units sold on December 23, 2021 by Dinesh V. Patel Ph.D. worth over $482.17K
  • In the last 5 years, insiders at Protagonist Therapeutics, Inc sold an estimated value of $7.29M and bought an estimated value of $36.13M
  • The most active traders are Dinesh V. Patel Ph.D., President and CEO,  David yLiu, Chief Scientific Officer,  and Richard S Shames, Chief Medical Officer
  • Insider trading is most common in May, with the busiest year in 2018

Protagonist Therapeutics, Inc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1